Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
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
xePxDsbQUP5FgN9y
Listen
